Senior insider sale
Chief Financial Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$57.5K
14.07K shares
What this filing means
JORGENSEN NATHAN D. plans to sell 14.07K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $57.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001959173-26-003638
Officer· Chief Financial Officer
Since Feb 2026
14.07K
Shares to sell
$57.5K
Approx. market value
9.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Option Granted - 02/06/2026
Cash
5/15/2026
9.41KTotal acquired9.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Option Granted - 02/06/2026 Cash | 9.41K | — |
| Total | 9.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.67K
Market value
$17.6K
2/24/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.41K
Market value
$39.9K
5/15/2026
Total
Units
14.07K
Value
$57.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/24/2026 | 4.67K | $17.6K | — | Completed |
| Planned — Approximate Date | ||||
5/15/2026 | 9.41K | $39.9K | NASDAQ | Planned |
| Total | 14.07K | $57.5K | ||